Cargando…

Next Generation Sequencing Technology in the Clinic and Its Challenges

SIMPLE SUMMARY: Precise identification and annotation of mutations are of utmost importance in clinical oncology. Insights of the DNA sequence can provide meaningful knowledge to unravel the underlying genetics of disease. Hence, tailoring of personalized medicine often relies on specific genomic al...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vestergaard, Lau K., Oliveira, Douglas N. P., Høgdall, Claus K., Høgdall, Estrid V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067551/ https://www.ncbi.nlm.nih.gov/pubmed/33916923 http://dx.doi.org/10.3390/cancers13081751

Ejemplares similares

Oncomine™ Comprehensive Assay v3 vs. Oncomine™ Comprehensive Assay Plus
por: Vestergaard, Lau K., et al.
Publicado: (2021)

Potential Targeted Therapies in Ovarian Cancer
por: Sisman, Yagmur, et al.
Publicado: (2022)

Integrated microRNA and mRNA signatures associated with overall survival in epithelial ovarian cancer
por: Lopacinska-Jørgensen, Joanna, et al.
Publicado: (2021)

Strategies for data normalization and missing data imputation and consequences for potential diagnostic microRNA biomarkers in epithelial ovarian cancer
por: Lopacinska-Jørgensen, Joanna, et al.
Publicado: (2023)

Gene expression profile association with poor prognosis in epithelial ovarian cancer patients
por: Oliveira, Douglas V. N. P., et al.
Publicado: (2021)

Genomic Sub-Classification of Ovarian Clear Cell Carcinoma Revealed by Distinct Mutational Signatures
por: Oliveira, Douglas V. N. P., et al.
Publicado: (2021)

Noncoding RNA (ncRNA) Profile Association with Patient Outcome in Epithelial Ovarian Cancer Cases
por: Oliveira, Douglas V. N. P., et al.
Publicado: (2020)

Organoids and epithelial ovarian cancer - a future tool for personalized treatment decisions? (Review)
por: Sisman, Yagmur, et al.
Publicado: (2022)

DNA Methylation in Ovarian Tumors—a Comparison Between Fresh Tissue and FFPE Samples
por: Oliveira, Douglas V.N.P., et al.
Publicado: (2021)

Expression Stability Analysis of Candidate References for Normalization of RT-qPCR Data Using RefSeeker R package
por: Petersen, Patrick H.D., et al.
Publicado: (2023)

Identification of stably expressed microRNAs in plasma from high-grade serous ovarian carcinoma and benign tumor patients
por: Petersen, Patrick H.D., et al.
Publicado: (2023)

Searching for new biomarkers in ovarian cancer patients: Rationale and design of a retrospective study under the Mermaid III project
por: Hentze, Julie L., et al.
Publicado: (2017)

Measuring KRAS Mutations in Circulating Tumor DNA by Droplet Digital PCR and Next-Generation Sequencing
por: Demuth, Christina, et al.
Publicado: (2018)

Diagnostic plasma miRNA-profiles for ovarian cancer in patients with pelvic mass
por: Oliveira, Douglas Nogueira Perez, et al.
Publicado: (2019)

The potential role of infectious agents and pelvic inflammatory disease in ovarian carcinogenesis
por: Ingerslev, Kasper, et al.
Publicado: (2017)

Survival and recurrence in stage II endometrial cancers in relation to uterine risk stratification after introduction of lymph node resection and omission of postoperative radiotherapy: a Danish Gynecological Cancer Group Study
por: Ørtoft, Gitte, et al.
Publicado: (2019)

Identification and validation of potential prognostic and predictive miRNAs of epithelial ovarian cancer
por: Prahm, Kira Philipsen, et al.
Publicado: (2018)

The prevalence of EBV and CMV DNA in epithelial ovarian cancer
por: Ingerslev, Kasper, et al.
Publicado: (2019)

PAPP-A proteolytic activity enhances IGF bioactivity in ascites from women with ovarian carcinoma
por: Thomsen, Jacob, et al.
Publicado: (2015)

Circulating Antinuclear Antibodies in Patients with Pelvic Masses Are Associated with Malignancy and Decreased Survival
por: Heegaard, Niels H. H., et al.
Publicado: (2012)

MicroRNA characteristics in epithelial ovarian cancer
por: Prahm, Kira Philipsen, et al.
Publicado: (2021)

Test of the FlashFREEZE unit in tissue samples freezing for biobanking purposes
por: Biskup, Edyta, et al.
Publicado: (2022)

High-risk HPV is not associated with epithelial ovarian cancer in a Caucasian population
por: Ingerslev, Kasper, et al.
Publicado: (2016)

Lymph-vascular space invasion (LVSI) as a strong and independent predictor for non-locoregional recurrences in endometrial cancer: a Danish Gynecological Cancer Group Study
por: Ørtoft, Gitte, et al.
Publicado: (2019)

Markers aiding the diagnosis of chondroid tumors: an immunohistochemical study including osteonectin, bcl-2, cox-2, actin, calponin, D2-40 (podoplanin), mdm-2, CD117 (c-kit), and YKL-40
por: DAUGAARD, SØREN, et al.
Publicado: (2009)

Improved migration of tumor ascites lymphocytes to ovarian cancer microenvironment by CXCR2 transduction
por: Idorn, Manja, et al.
Publicado: (2017)

Adjustment of serum HE4 to reduced glomerular filtration and its use in biomarker-based prediction of deep myometrial invasion in endometrial cancer
por: Chovanec, Josef, et al.
Publicado: (2017)

YKL-40 tissue expression and plasma levels in patients with ovarian cancer
por: Høgdall, Estrid VS, et al.
Publicado: (2009)

Next generation sequencing technologies for next generation plant breeding
por: Ray, Soham, et al.
Publicado: (2014)

Clinical validation of chemotherapy predictors developed on global microRNA expression in the NCI60 cell line panel tested in ovarian cancer
por: Prahm, Kira Philipsen, et al.
Publicado: (2017)

Identification of new biomarkers to promote personalised treatment of patients with inflammatory rheumatic disease: protocol for an open cohort study
por: Kringelbach, Tina Marie, et al.
Publicado: (2018)

MicroRNA Biomarkers in IBD—Differential Diagnosis and Prediction of Colitis-Associated Cancer
por: James, Jaslin P., et al.
Publicado: (2020)

Next-Generation Sequencing Technology: Current Trends and Advancements
por: Satam, Heena, et al.
Publicado: (2023)

The impact of metabolic supply lines - and the patterns between them - on the development of distant metastases in 64 women with breast cancer
por: Abrahamsen, Oliver, et al.
Publicado: (2022)

The evolution of next-generation sequencing technologies
por: Akintunde, Olaitan, et al.
Publicado: (2023)

Comparison of next generation sequencing technologies for transcriptome characterization
por: Wall, P Kerr, et al.
Publicado: (2009)

Scenario drafting for early technology assessment of next generation sequencing in clinical oncology
por: Joosten, S.E.P., et al.
Publicado: (2016)

Next-generation sequencing and its clinical application
por: Qin, Dahui
Publicado: (2019)

The influence of insulin-related genetic variants on fetal growth, fetal blood flow, and placental weight in a prospective pregnancy cohort
por: Reim, Pauline K., et al.
Publicado: (2023)

A Highly Sensitive Quantitative Real-Time PCR Assay for Determination of Mutant JAK2 Exon 12 Allele Burden
por: Kjær, Lasse, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_7randb6h9j2s5fked1rd8sr647